BPI
COLL icon

BFC Planning, Inc.’s Collegium Pharmaceutical COLL Stock Holding History

BFC Planning, Inc.’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.34K Buy
258
+34
+15% +$1.16K ﹤0.01% 2403
2026
Q1 		$7.41K Hold
224
– – ﹤0.01% 2155
2025
Q4 		$10.4K Buy
224
+15
+7% +$628 ﹤0.01% 2063
2025
Q3 		$7.31K Hold
209
– – ﹤0.01% 2058
2025
Q2 		$6.18K Sell
209
-262
-56% -$7.47K ﹤0.01% 1984
2025
Q1 		$14.1K Hold
471
– – ﹤0.01% 1617
2024
Q4 		$13.5K Buy
+471
New +$15.6K ﹤0.01% 1632

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BFC Planning, Inc.'s COLL Position: Q2 2026 in Review

BFC Planning, Inc. increased its Collegium Pharmaceutical (COLL) stake by 15% in Q2 2026, buying an estimated $1.16K and bringing the position to 258 shares worth $9.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

BFC Planning, Inc. first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.1K in Q1 2025. 281 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • BFC Planning, Inc. held 258 shares of Collegium Pharmaceutical worth $9.34K as of Q2 2026.
  • BFC Planning, Inc. bought 34 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.16K.
  • Collegium Pharmaceutical made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2403 holding.
  • BFC Planning, Inc. first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Collegium Pharmaceutical position peaked at $14.1K in Q1 2025.
  • 281 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.